# Multiple Ascending Dose Study in Subjects With Type 2 Diabetes

> **NCT01856881** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 86 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** AMG 876

## Key facts

- **NCT ID:** NCT01856881
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-03
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** This study was terminated on August 29th, 2014 due to a business decision by the Sponsor. The study was not terminated due to a safety reason.
- **Last updated:** 2015-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856881, "Multiple Ascending Dose Study in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01856881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*